Previous studies have reported that potato carboxypeptidase inhibitors can inhibit the proliferation of pancreatic cancer by acting as a competitive inhibitor of epidermal growth factor (EGF) and by binding to EGFR [40]. Here, EGF is linked to familial pancreatic carcinoma.